Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Found 317 studies with search of: | "Ribavirin" |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Recruiting |
Peginterferon Alfa-2a and Ribavirin for Genotype 2 Chronic Hepatitis C: Duration and Ribavirin Dose Stratified by RVR
|
||||
2 | Recruiting |
Combination Therapy With Pegylated Interferon and Ribavirin in Patients With Chronic Hepatitis C Genotype 2 or 3 Infection Who Previously Have Relapsed After Therapy With Pegylated Interferon and Ribavirin
|
||||
3 | Recruiting |
Pegasys® Plus Ribavirin in Hemophilic Patients With Hepatitis C Virus Infection
|
||||
4 | Recruiting |
Four Arms, Multicenter Study of Tailored Regimens With Peginterferon Plus Ribavirin for Genotype 2 Chronic Hepatitis C
|
||||
5 | Completed |
Study of Nitazoxanide, Peginterferon, and Ribavirin Combination Therapies in the Treatment of Chronic Hepatitis C
|
||||
6 | Completed |
Three Regimens of PEG-Intron Plus Ribavirin in Previously Untreated Chronic Hepatitis C, Genotype 2 or 3 (Study P03548AM2)(COMPLETED)
|
||||
7 | Recruiting |
Pegylated Interferon Plus Ribavirin in Treating Older Patients With Chronic Hepatitis C
|
||||
8 | Recruiting |
High-Dose Ribavirin in Treatment of Chronic Hepatitis C Genotype 1 or 4
|
||||
9 | Recruiting |
Effect of Infliximab on the Efficacy of Peg-Intron/Ribavirin in Patients With Hepatitis C (Study P04257AM1)
|
||||
10 | Not yet recruiting |
Pilot Comparison of Standard Antiviral Therapy With and Without 12 Weeks of Betaine in Genotype 1 Naive Patients
|
||||
11 | Recruiting |
Pegasys® Plus Ribavirin in Thalassemic Patients With Hepatitis C Virus Infection
|
||||
12 | Completed |
Extended Treatment With PEG-Intron and Rebetol in Patients With Genotype 1 Chronic Hepatitis C and Slow Virologic Response (Study P03685AM3)(COMPLETED)
|
||||
13 | Recruiting |
Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Malignancy Other Than Hepatocellular Carcinoma
|
||||
14 | Completed |
A Randomized Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for HCV Genotype-1 Patients
|
||||
15 | Recruiting |
Randomized Trial of 24 or 48 Weeks of Peginterferon Alfa-2a Plus Ribavirin for HCV Genotype 1-Infected Patients
|
||||
16 | Recruiting |
A Study of Combination Treatment With PEGASYS (Peginterferon Alfa-2a (40KD) Plus COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C.
|
||||
17 | Recruiting |
Low Dose Peginterferon-α 2a for Chronic Hepatitis C, Genotypes 2 or 3, in HIV-Coinfected Patients
|
||||
18 | Completed |
REPEAT Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Therapy in Combination With COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Who Did Not Respond to Previous PegIntron (Peginterferon Alfa-2b (12KD))/Ribavirin Combination Therapy
|
||||
19 | Recruiting |
Pretreatment With Ribavirin Before Peginterferon and Ribavirin Therapy for Chronic Hepatitis C
|
||||
20 | Completed |
Peg-Ifn Dose Evaluations for Previously Untreated Subjects With Chronic Hepatitis C Infected With Genotype 1 (Study P03471AM1)(COMPLETED)
|
Previous Page | Studies Shown (1-20) | Next (21-40) |